Target intelligence / Profile preview

Ethanolamine kinase 2 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

Ethanolamine kinase 2 pseudogene (ENSG00000274468) is a nonfunctional segment of DNA that shows sequence similarity to the functional ethanolamine kinase 2 gene but lacks the capability to encode a protein due to disabling mutations such as premature stop codons or frameshifts[2][1]. Pseudogenes are abundant in the human genome and generally considered genomic relics, although occasionally some pseudogenes may be transcribed and play limited regulatory roles, often by acting as non-coding RNAs or competitive endogenous RNAs in gene expression networks[3]. However, the majority of pseudogenes, including the ethanolamine kinase 2 pseudogene, do not have proven functional protein products and are not used as drug targets, disease markers, or clinical therapeutic entities[1][2][3]. Summary: ENSG00000274468 refers to a pseudogene—not a receptor, enzyme, transporter, or established molecular target—and should not be confused with its functional counterpart, ethanolamine kinase 2. It does not encode a protein, does not participate as a direct therapeutic target, and has no known clinical or pharmacological significance[2][1][3].

02

Biological functions

Can act as a long non-coding RNA or influence gene expression at the RNA level in rare casesTypically considered nonfunctional or without protein-coding ability
03

Disease associations

Other (in rare situations, pseudogenes or their transcripts may play a regulatory role in disease processes, but there is no specific association for ethanolamine kinase 2 pseudogene)

Beyond the preview

Go deeper on Ethanolamine kinase 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ethanolamine kinase 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call